Necroptotic signaling in adaptive and innate immunity

Seminars in Cell and Developmental Biology

Volumn 35, Issue , 2014, Pages 33-39

  Lu, Jennifer V ^a   Chen, Helen C ^a   Walsh, Craig M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Cell death; Immune system; Immunity; Necroptosis; T cells

Indexed keywords

CASPASE 8; DEATH RECEPTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; MLKL PROTEIN, HUMAN; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK1 PROTEIN, HUMAN; RIPK3 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; APOPTOSIS; CELL DEATH; CELL FUNCTION; CELL STIMULATION; GENOTOXICITY; HOST RESISTANCE; IMMUNOMODULATION; INFECTION; INNATE IMMUNITY; NECROPTOSIS; NECROSIS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE INJURY; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; METABOLISM;

ADAPTIVE IMMUNITY; CASPASE 8; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; NECROSIS; PROTEIN KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 84908661543     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.07.003     Document Type: Review

References (107)

1. Walsh C.M., Luhrs K.A., Arechiga A.F. The "fuzzy logic" of the death-inducing signaling complex in lymphocytes. J Clin Immunol 2003, 23(5):333-353.
2. Vanlangenakker N., Vanden Berghe T., Vandenabeele P. Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 2012, 19(1):75-86.
3. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., Mizushima N., et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005, 1(2):112-119.
4. Walsh C.M., Bell B.D. T cell intrinsic roles of autophagy in promoting adaptive immunity. Curr Opin Immunol 2010, 22(3):321-325.
5. Mocarski E.S., Kaiser W.J., Livingston-Rosanoff D., Upton J.W., Daley-Bauer L.P. True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J Immunol 2014, 192(5):2019-2026.
6. Weinlich R., Dillon C.P., Green D.R. Ripped to death. Trends Cell Biol 2011, 21(11):630-637.
7. Kaiser W.J., Upton J.W., Long A.B., Livingston-Rosanoff D., Daley-Bauer L.P., Hakem R., et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011, 471(7338):368-372.
8. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114(2):181-190.
9. Gerlach B., Cordier S.M., Schmukle A.C., Emmerich C.H., Rieser E., Haas T.L., et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011, 471(7340):591.
10. Bertrand M.J., Milutinovic S., Dickson K.M., Ho W.C., Boudreault A., Durkin J., et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 2008, 30(6):689-700.
11. O'Donnell M.A., Ting A.T. NFκB and ubiquitination: partners in disarming RIPK1-mediated cell death. Immunol Res 2012, 54(1-3):214-226.
12. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996, 274(5288):787-789.
13. Varfolomeev E., Goncharov T., Fedorova A.V., Dynek J.N., Zobel K., Deshayes K., et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation. J Biol Chem 2008, 283(36):24295-24299.
14. Mahoney D.J., Cheung H.H., Mrad R.L., Plenchette S., Simard C., Enwere E., et al. Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation. Proc Natl Acad Sci U S A 2008, 105(33):11778-11783.
15. Varfolomeev E., Blankenship J.W., Wayson S.M., Fedorova A.V., Kayagaki N., Garg P., et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 2007, 131(4):669-681.
16. Vince J.E., Wong W.W., Khan N., Feltham R., Chau D., Ahmed A.U., et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007, 131(4):682-693.
17. Zarnegar B.J., Wang Y., Mahoney D.J., Dempsey P.W., Cheung H.H., He J., et al. Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol 2008, 9(12):1371-1378.
18. Moquin D.M., McQuade T., Chan F.K.-M. CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis. PLoS ONE 2013, 8(10):e76841.
19. Hitomi J., Christofferson D.E., Ng A., Yao J., Degterev A., Xavier R.J., et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135(7):1311-1323.
20. Wang L., Du F., Wang X. TNF-α induces two distinct caspase-8 activation pathways. Cell 2008, 133(4):693-703.
21. Chang D.W., Xing Z., Capacio V.L., Peter M.E., Yang X. Interdimer processing mechanism of procaspase-8 activation. EMBO J 2003, 22(16):4132-4142.
22. Lin Y., Devin A., Rodriguez Y., Liu Z.G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Develop 1999, 13(19):2514-2526.
23. Rébé C., Cathelin S., Launay S., Filomenko R., Prévotat L., L'Ollivier C., et al. Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood 2007, 109(4):1442-1450.
24. Feng S., Yang Y., Mei Y., Ma L., Zhu D.E., Hoti N., et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signall 2007, 19(10):2056-2067.
25. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., Pop C., et al. Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis. Nature 2011, 471(7338):363-367.
26. O'Donnell M.A., Perez-Jimenez E., Oberst A., Ng A., Massoumi R., Xavier R., et al. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 2011, 13(12):1437.
27. Bertrand M.J., Vandenabeele P. The ripoptosome: death decision in the cytosol. Mol Cell 2011, 43(3):323-325.
28. Lu J.V., Walsh C.M. Programmed necrosis and autophagy in immune function. Immunol Rev 2012, 249(1):205-217.
29. Declercq W., Vanden Berghe T., Vandenabeele P. RIP kinases at the crossroads of cell death and survival. Cell 2009, 138(2):229-232.
30. Sun X., Yin J., Starovasnik M.A., Fairbrother W.J., Dixit V.M. Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 2002, 277(11):9505-9511.
31. Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., Guildford M., et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137(6):1112-1123.
32. Cai Z., Jitkaew S., Zhao J., Chiang H.C., Choksi S., Liu J., et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 2013, 16(1):55-65.
33. He S., Wang L., Miao L., Wang T., Du F., Zhao L., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 2009, 137(6):1100-1111.
34. Chen W., Zhou Z., Li L., Zhong C.Q., Zheng X., Wu X., et al. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J Biol Chem 2013, 288(23):16247-16261.
35. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000, 1(6):489-495.
36. Zhang D.W., Shao J., Lin J., Zhang N., Lu B.J., Lin S.C., et al. RIP3, an energy metabolism regulator that switches tnf-induced cell death from apoptosis to necrosis, in Science. Am Assoc Adv Sci 2009, 332-336.
37. Jouan-Lanhouet S., Arshad M.I., Piquet-Pellorce C., Martin-Chouly C., Le Moigne-Muller G., Van Herreweghe F., et al. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ 2012, 19(12):2003-2014.
38. Matsumura H., Simizu Y., Ohsawa Y., Kawahara A., Uchiyama Y., Nagata S. Necrotic death pathway in Fas receptor signaling. J Cell Biol 2000, 151(6):1247-1256.
39. Stanger B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 1995, 81(4):513-523.
40. Li J.X., Feng J.M., Wang Y., Li X.H., Chen X.X., Su Y., et al. The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury. Cell Death Dis 2014, 5(6):e1278.
41. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999, 5(11):1249-1255.
42. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413(6857):732-738.
43. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000, 105(4):497-504.
44. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5(10):987.
45. Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011, 30(1):16-34.
46. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., Kelliher M., et al. RIP1 is an essential mediator of Toll-like receptor 3--induced NF-kappaB activation. Nat Immunol 2004, 5(5):503-507.
47. Cusson-Hermance N., Khurana S., Lee T.H., Fitzgerald K.A., Kelliher M.A. Rip1 mediates the Trif-dependent toll-like receptor 3-and 4-induced NF-kappaB activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 2005, 280(44):36560-36566.
48. He S., Liang Y., Shao F., Wang X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci 2011, 108(50):20054-20059.
49. Kaiser W.J., Offermann M.K. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol 2005, 174(8):4942-4952.
50. Ma Y., Temkin V., Liu H., Pope R.M. NF-κB protects macrophages from lipopolysaccharide-induced cell death. J Biol Chem 2005, 280(51):41827-41834.
51. Upton J.W., Kaiser W.J., Mocarski E.S. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 2010, 7(4):302-313.
52. Yuan J., Kroemer G. Alternative cell death mechanisms in development and beyond. Genes Dev 2010, 24(23):2592-2602.
53. Shulga N., Pastorino J.G. GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis. J Cell Sci 2012, 125(Pt 12):2995-3003.
54. Tenev T., Bianchi K., Darding M., Broemer M., Langlais C., Wallberg F., et al. The ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011, 43(3):432-448.
55. Feoktistova M., Geserick P., Kellert B., Dimitrova D.P., Langlais C., Hupe M., et al. cIAPs block ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011, 43(3):449-463.
56. Donepudi M., Mac Sweeney A., Briand C., Grütter M.G. Insights into the regulatory mechanism for caspase-8 activation. Mol Cell 2003, 11(2):543-549.
57. Vercammen D., Vandenabeele P., Beyaert R., Declercq W., Fiers W. Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells. Cytokine 1997, 9(11):801-808.
58. Ermolaeva M.A., Michallet M.C., Papadopoulou N., Utermöhlen O., Kranidioti K., Kollias G., et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat Immunol 2008, 9(9):1037-1046.
59. Harper N., Hughes M., MacFarlane M., Cohen G.M. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J Biol Chem 2003, 278(28):25534-25541.
60. Ting A.T., Pimentel-Muinos F.X., Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J 1996, 15(22):6189-6196.
61. Hsu H., Huang J., Shu H.B., Baichwal V., Goeddel D.V., et al. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996, 4(4):387-396.
62. Ea C.K., Deng L., Xia Z.P., Pineda G., Chen Z.J. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006, 22(2):245-257.
63. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995, 14(22):5579-5588.
64. He S., Wang L., Miao L., Wang T., Du F., Zhao L., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137(6):1100-1111.
65. Zhang D.W., Shao J., Lin J., Zhang N., Lu B.J., Lin S.C., et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009, 325(5938):332-336.
66. Degterev A., Hitomi J., Germscheid M., Ch'en I.L., Korkina O., Teng X., et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008, 4(5):313-321.
67. Lu J.V., Weist B.M., van Raam B.J., Marro B.S., Nguyen L.V., Srinivas P., et al. Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A 2011, 108(37):15312-15317.
68. Sun L., Wang H., Wang Z., He S., Chen S., Liao D., et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012, 148(1-2):213-227.
69. Murphy J.M., Czabotar P.E., Hildebrand J.M., Lucet I.S., Zhang J.G., Alvarez-Diaz S., et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013, 39(3):443-453.
70. Wu J., Huang Z., Ren J., Zhang Z., He P., Li Y., et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res 2013, 23(8):994-1006.
71. Newton K., Dugger D.L., Wickliffe K.E., Kapoor N., Cristina de-Almagro M., Vucic D., et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 2014, 343(6177):1357-1360.
72. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacob W.A., Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992, 267(8):5317-5323.
73. Wang Z., Jiang H., Chen S., Du F., Wang X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 2012, 148(1-2):228-243.
74. Ch'en I.L., Beisner D.R., Degterev A., Lynch C., Yuan J., Hoffmann A., et al. Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc Natl Acad Sci U S A 2008, 105(45):17463-17468.
75. Bell B.D., Leverrier S., Weist B.M., Newton R.H., Arechiga A.F., Luhrs K.A., et al. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci U S A 2008, 105(43):16677-16682.
76. Ch'en I.L., Tsau J.S., Molkentin J.D., Komatsu M., Hedrick S.M. Mechanisms of necroptosis in T cells. J Exp Med 2011, 208(4):633-641.
77. Salmena L., Lemmers B., Hakem A., Matysiak-Zablocki E., Murakami K., Au P.Y., et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003, 17(7):883-895.
78. Osborn S.L., Diehl G., Han S.J., Xue L., Kurd N., Hsieh K., et al. Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proc Natl Acad Sci U S A 2010, 107(29):13034-13039.
79. Newton K., Harris A.W., Bath M.L., Smith K.G., Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J 1998, 17(3):706-718.
80. Walsh C.M., Wen B.G., Chinnaiyan A.M., O'Rourke K., Dixit V.M., Hedrick S.M. A role for FADD in T cell activation and development. Immunity 1998, 8(4):439-449.
81. Degterev A., Maki J.L., Yuan J. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ 2013, 20(2):366.
82. Zhang H., Zhou X., McQuade T., Li J., Chan F.K., Zhang J. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 2011, 471(7338):373-376.
83. Dillon C.P., Oberst A., Weinlich R., Janke L.J., Kang T.B., Ben-Moshe T., et al. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 2012, 1(5):401-407.
84. Beisner D.R., Chu I.H., Arechiga A.F., Hedrick S.M., Walsh C.M. The requirements for fas-associated death domain signaling in mature T cell activation and survival. J Immunol 2003, 171(1):247-256.
85. Mocarski E.S., Upton J.W., Kaiser W.J. Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol 2012, 12(2):79-88.
86. Bohgaki T., Mozo J., Salmena L., Matysiak-Zablocki E., Bohgaki M., Sanchez O., et al. Caspase-8 inactivation in T cells increases necroptosis and suppresses autoimmunity in Bim-/- mice. J Cell Biol 2011, 195(2):277-291.
87. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Köntgen F., et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999, 286(5445):1735-1738.
88. Strasser A. The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005, 5(3):189-200.
89. Weber A., Kirejczyk Z., Besch R., Potthoff S., Leverkus M., Häcker G. Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell Death Differ 2010, 17(6):942-951.
90. Martinon F., Gaide O., Pétrilli V., Mayor A., Tschopp J. NALP inflammasomes: a central role in innate immunity. Semin Immunopathol 2007, 29(3):213-229.
91. Ma Y., Temkin V., Liu H., Pope R.M. NF-kappaB protects macrophages from lipopolysaccharide-induced cell death: the role of caspase 8 and receptor-interacting protein. J Biol Chem 2005, 280(51):41827-41834.
92. Kalai M., Van Loo G., VandenBerghe T., Meeus A., Burm W., Saelens X., et al. Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA. Cell Death Differ 2002, 9(9):981-994.
93. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301(5633):640-643.
94. Wang F., Lu Z., Hawkes M., Yang H., Kain K.C., Liles W.C. Fas (CD95) induces rapid TLR4/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophages. J Inflamm (Lond) 2010, 7:30.
95. Rajput A., Kovalenko A., Bogdanov K., Yang S.H., Kang T.B., Kim J.C., et al. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity 2011, 34(3):340-351.
96. Upton J.W., Kaiser W.J., Mocarski E.S. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 2012, 11(3):290-297.
97. Kawadler H., Gantz M.A., Riley J.L., Yang X. The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Mol Cell 2008, 31(3):415-421.
98. Misra R.S., Russell J.Q., Koenig A., Hinshaw-Makepeace J.A., Wen R., Wang D., et al. Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation. J Biol Chem 2007, 282(27):19365-19374.
99. Arechiga A.F., Bell B.D., Leverrier S., Weist B.M., Porter M., Wu Z., et al. A Fas-associated death domain protein/caspase-8-signaling axis promotes S-phase entry and maintains S6 kinase activity in T cells responding to IL-2. J Immunol 2007, 179(8):5291-5300.
100. Bray K., Mathew R., Lau A., Kamphorst J.J., Fan J., Chen J., et al. Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition. PLoS ONE 2012, 7(7):e41831.
101. He M.X., McLeod I.X., Jia W., He Y.W. Macroautophagy in T lymphocyte development and function. Front Immunol 2012, 3:22.
102. Youle R.J., Narendra D.P. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011, 12(1):9-14.
103. Bell B.D., Walsh C.M. Coordinate regulation of autophagy and apoptosis in T cells by death effectors: FADD or foundation. Autophagy 2009, 5(2):238-240.
104. O'Donnell M.A., Perez-Jimenez E., Oberst A., Ng A., Massoumi R., Xavier R., et al. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 2011, 13(12):1437-1442.
105. Varfolomeev E.E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J.S., Mett I.L., et al. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998, 9(2):267-276.
106. Zhang J., Cado D., Chen A., Kabra N.H., Winoto A., et al. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998, 392(6673):296-300.
107. Yeh W.C., de la Pompa J.L., McCurrach M.E., Shu H.B., Elia A.J., Shahinian A., et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998, 279(5358):1954-1958.